According to ITP guidelines, when aPL are detected in an ITP patient without a history of thrombosis or obstetric complications, this finding will not change the diagnosis of primary ITP nor the recommended treatment (with an important caveat on thrombopoietin receptor agonists, discussed in a dedicated section). Here, MPL is linked to autoimmune thrombocytopenic purpura.